Sanofi And GSK Delay COVID-19 Vaccine, Marking Setback For Global Fight

Sanofi and GlaxoSmithKline said clinical trials of their COVID19 vaccine showed an insufficient immune response in older people, delaying its launch to late next year and marking a setback in the global fight against the pandemic.

from Top Business News- News18.com https://ift.tt/3m6qOwr

• Tweet
• Share
• Share
• Share
• Share